Bilbao I - Search Results

1

High intrapatient variability of tacrolimus exposure associated with poorer outcomes in liver transplantation.

Dopazo C, Bilbao I, García S, Gómez-Gavara C, Caralt M, Campos-Varela I, Castells L, Hidalgo E, Moreso F, Montoro B, Charco R. Dopazo C, et al. Among authors: bilbao i. Clin Transl Sci. 2022 Jun;15(6):1544-1555. doi: 10.1111/cts.13276. Epub 2022 Apr 19. Clin Transl Sci. 2022. PMID: 35373449 Free PMC article.

2

Experience in therapy of chronic liver allograft rejection.

Charco R, Ruiz C, Allende E, Balsells J, Lazaro JL, Murio E, Bilbao I, Gifre E, Margarit C. Charco R, et al. Among authors: bilbao i. Transplant Proc. 1995 Aug;27(4):2293-4. Transplant Proc. 1995. PMID: 7652811 No abstract available.

3

Liver transplantation in patients over 60 years of age.

Bilbao I, Balsells J, Lazaro JL, Charco R, Murio E, Gifre E, Ruiz C, Edo A, Margarit C. Bilbao I, et al. Transplant Proc. 1995 Aug;27(4):2337-8. Transplant Proc. 1995. PMID: 7652834 No abstract available.

4

Evolution of biliary complications in liver transplantation without biliary drainage.

Balsells J, Lázaro JL, Murio JE, Charco R, Bilbao I, Gifre E, Ruíz C, Margarit C. Balsells J, et al. Among authors: bilbao i. Transplant Proc. 1995 Aug;27(4):2339-40. Transplant Proc. 1995. PMID: 7652835 No abstract available.

5

Is hepatitis C virus recurrence a risk factor for chronic liver allograft rejection?

Charco R, Vargas V, Allende H, Edo A, Balsells J, Murio E, Lázaro JL, Bilbao I, Margarit C. Charco R, et al. Among authors: bilbao i. Transpl Int. 1996;9 Suppl 1:S195-7. doi: 10.1007/978-3-662-00818-8_49. Transpl Int. 1996. PMID: 8959825

6

Risk factors for severe ischemic injury after liver transplantation.

Bilbao I, Charco R, Hidalgo E, Lázaro JL, Balsells J, Murio E, Margarit C. Bilbao I, et al. Transplant Proc. 1997 Feb-Mar;29(1-2):368-70. doi: 10.1016/s0041-1345(96)00123-6. Transplant Proc. 1997. PMID: 9123041 No abstract available.

7

Risk factors for acute renal failure requiring dialysis after liver transplantation.

Bilbao I, Charco R, Balsells J, Lazaro JL, Hidalgo E, Llopart L, Murio E, Margarit C. Bilbao I, et al. Clin Transplant. 1998 Apr;12(2):123-9. Clin Transplant. 1998. PMID: 9575400

8

Experience with neoral cyclosporine through the oral route in liver transplantation.

Bilbao I, Lazaro JL, Pou L, Charco R, Hildalgo E, Murio E, Margarit C. Bilbao I, et al. Transplant Proc. 1998 Jun;30(4):1432-4. doi: 10.1016/s0041-1345(98)00303-0. Transplant Proc. 1998. PMID: 9636580 Clinical Trial. No abstract available.

9

Early use of tacrolimus as rescue therapy for refractory liver allograft rejection.

Charco R, Murio E, Edo A, Balsells J, Lázaro JL, Bilbao I, Hidalgo E, Margarit C. Charco R, et al. Among authors: bilbao i. Transpl Int. 1998;11 Suppl 1:S313-7. doi: 10.1007/s001470050486. Transpl Int. 1998. PMID: 9665004 Clinical Trial.

10

Therapeutic drug monitoring of tacrolimus in liver transplantation, phase III FK506 multicenter Spanish Study Group: a two-year follow-up.

Pou L, Brunet M, Bilbao I, Andreu H, Andres I, Lopez R, Margarit C, Rimola A, Corbella J. Pou L, et al. Among authors: bilbao i. Ther Drug Monit. 1998 Dec;20(6):602-6. doi: 10.1097/00007691-199812000-00003. Ther Drug Monit. 1998. PMID: 9853973 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

189 results

Search Page